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Clinics and pathology 
Disease 
Atypical M3 ANLL (in most cases, M3 ANLL is 
characterized by a t(15;17)(q25;q21)). 
Epidemiology 
Exceptional (only 1 case fully described), a 6 mth old 
male patient. 
Clinics 
Multiple cutaneous localizations; blue-green macules 
on the scalp and the trunk; coagulation parameters and 
platelets count were normal. 
Prognosis 
Complet remission obtained with ATRA treatment and 
autologous bone marrow transplantation (38 mths 





3 related translocations observed in M3 ANLL; the first 
is the common translocation (15;17) and the two others 
are extremelly rare; all these translocations involve a 
breakpoint at 17q21, in RARa, which fuses with 
different partners: 1- t(15;17)(q22;q21), fusion with 
PML in 15q22; 2- t(5;17)(q32;q12), fusion with NPM1 
in 5q32, encoding for a RNA processing protein; 3- 










NuMA protein is an essential component for the 
formation and maintenance of mitotic spindle poles 





Wide expression; nuclear receptor; binds specific DNA 
sequences: HRE (hormone response elements); ligand 
and dimerization domain; role in growth and 
differentiation. 




Fusion gene on der(11) encompassed by a lamba phage 
clone B350g; breakpoint in RARa gene in the usual 
breakpoint cluster region within intron 2. 
Transcript 
5' NuMA - 3' RARa transcript; no reciprocal 5' RARa - 
3' NuMA transcript can be detected. 
Fusion protein 
Description 
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globular domain and the alpha helical dimerization  
domain of NuMA (amino acids 1 to 1883) linked to the 
ligand-binding, dimerization and DNA-binding 
domains of RARa (amino acids 61 to 462). 
Expression localisation 
Nuclear localisation, under the form of sheet-like 
nuclear aggregates which partially co-localizes with 
normal NuMA protein. 
Oncogenesis 
As for the three other translocations associated with 
APL, the main consequence of NuMA-RARa fusion 
seems to be an alteration in the retinoid signalling 
pathway; as for PML, PLZF or NPM, NuMA, the forth 
fusion partner of RARa would “share the capacity to 
participate in protein-protein interactions, which may  
result in the formation of abnormal heterodimers or 
aggregates in which co-activators of retinoid signalli g 
are sequestered”. 
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